These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8387927)
21. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Conn PJ; Sanders-Bush E; Hoffman BJ; Hartig PR Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4086-8. PubMed ID: 2940597 [TBL] [Abstract][Full Text] [Related]
22. Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABAA receptors. Wong G; Kuoppamäki M; Hietala J; Lüddens H; Syvälahti E; Korpi ER Eur J Pharmacol; 1996 Oct; 314(3):319-23. PubMed ID: 8957253 [TBL] [Abstract][Full Text] [Related]
23. Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite. Young CD; Meltzer HY; Deutch AY Neuropsychopharmacology; 1998 Jul; 19(1):99-103. PubMed ID: 9608582 [TBL] [Abstract][Full Text] [Related]
24. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Schotte A; Janssen PF; Megens AA; Leysen JE Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574 [TBL] [Abstract][Full Text] [Related]
26. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Sanders-Bush E; Burris KD; Knoth K J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634 [TBL] [Abstract][Full Text] [Related]
27. Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. Canton H; Verrièle L; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(1):93-6. PubMed ID: 1982659 [TBL] [Abstract][Full Text] [Related]
28. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Seeman P; Corbett R; Van Tol HH Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795 [TBL] [Abstract][Full Text] [Related]
29. Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain. Hietala J; Koulu M; Kuoppamäki M; Lappalainen J; Syvälahti E Prog Neuropsychopharmacol Biol Psychiatry; 1992 Sep; 16(5):727-32. PubMed ID: 1496128 [TBL] [Abstract][Full Text] [Related]
30. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics. Assié MB; Sleight AJ; Koek W Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973 [TBL] [Abstract][Full Text] [Related]
31. Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model. Godoy T; Riva A; Ekström J Eur J Oral Sci; 2011 Aug; 119(4):275-81. PubMed ID: 21726287 [TBL] [Abstract][Full Text] [Related]
32. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus. Brown AM; Patch TL; Kaumann AJ Br J Pharmacol; 1991 Sep; 104(1):45-8. PubMed ID: 1786517 [TBL] [Abstract][Full Text] [Related]
33. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile. Malgouris C; Flamand F; Doble A Eur J Pharmacol; 1993 Mar; 233(1):29-35. PubMed ID: 8386088 [TBL] [Abstract][Full Text] [Related]
34. Distribution of clozapine and desmethylclozapine between blood and brain in rats. Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296 [TBL] [Abstract][Full Text] [Related]
35. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793 [TBL] [Abstract][Full Text] [Related]
36. Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation. Spalding TA; Ma JN; Ott TR; Friberg M; Bajpai A; Bradley SR; Davis RE; Brann MR; Burstein ES Mol Pharmacol; 2006 Dec; 70(6):1974-83. PubMed ID: 16959945 [TBL] [Abstract][Full Text] [Related]
38. In vivo occupation of dopamine D1, D2 and serotonin (5-HT)2A receptors by sertindole in the rat brain. Takahashi Y; Kusumi I; Ishikane T; Matsubara S; Koyama T J Psychiatry Neurosci; 1998 May; 23(3):157-62. PubMed ID: 9595889 [TBL] [Abstract][Full Text] [Related]
39. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213. Daly SA; Waddington JL Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875 [TBL] [Abstract][Full Text] [Related]
40. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity. Sur C; Mallorga PJ; Wittmann M; Jacobson MA; Pascarella D; Williams JB; Brandish PE; Pettibone DJ; Scolnick EM; Conn PJ Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13674-9. PubMed ID: 14595031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]